Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Nguyen

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|July 19, 2018
Germline-activating mutations in <i>PIK3CD</i> compromise B cell development and functionDanielle T Avery, Alisa Kane, Tina Nguyen, et al.
The Journal of Surgical Research|April 12, 2021
Management of Pediatric Breast Masses: A Multi-institutional Retrospective Cohort StudyAmy E Lawrence, Jacqueline Saito, Amanda Onwuka, et al.
Elife|March 15, 2018
IRF4 haploinsufficiency in a family with Whipple's diseaseAntoine Guérin, Gaspard Kerner, Nico Marr, et al.
The Journal of Surgical Research|August 6, 2022
Disparities in the Management of Pediatric Breast MassesMaria E Knaus, Amanda J Onwuka, Alexis Bowder, et al.
Molecular Therapy. Oncology|April 10, 2024
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2024
Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4<sup>+</sup> IL-9-expressing cellsGeetha Rao, Corinne D Mack, Tina Nguyen, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|May 30, 2025
Human LY9 governs CD4<sup>+</sup> T cell IFN-γ immunity to <i>Mycobacterium tuberculosis</i>Masato Ogishi, Julia Puchan, Rui Yang, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|July 19, 2018
Germline-activating mutations in <i>PIK3CD</i> compromise B cell development and functionDanielle T Avery, Alisa Kane, Tina Nguyen, et al.
The Journal of Surgical Research|April 12, 2021
Management of Pediatric Breast Masses: A Multi-institutional Retrospective Cohort StudyAmy E Lawrence, Jacqueline Saito, Amanda Onwuka, et al.
Elife|March 15, 2018
IRF4 haploinsufficiency in a family with Whipple's diseaseAntoine Guérin, Gaspard Kerner, Nico Marr, et al.
The Journal of Surgical Research|August 6, 2022
Disparities in the Management of Pediatric Breast MassesMaria E Knaus, Amanda J Onwuka, Alexis Bowder, et al.
Molecular Therapy. Oncology|April 10, 2024
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2024
Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4<sup>+</sup> IL-9-expressing cellsGeetha Rao, Corinne D Mack, Tina Nguyen, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|May 30, 2025
Human LY9 governs CD4<sup>+</sup> T cell IFN-γ immunity to <i>Mycobacterium tuberculosis</i>Masato Ogishi, Julia Puchan, Rui Yang, et al.
Pageof 9